Interfacial behavior of tetrapyridylporphyrin monolayer arrays

The behavior of monolayer films of free base 5,10,15,20-tetrapyridylporphinato (TPyP) and 5,10,15,20-tetrapyridylporphinato zinc(II) (ZnTPyP) on pure water, 0.1 M CdCl2, and 0.1 M CuCl2 subphases was investigated by surface pressure-area isotherms, specular X-ray reflectometry, and polarized total reflection X-ray absorption spectroscopy (PTRXAS). Surface pressure-area isotherms showed significant differences in the area per molecule on pure water compared to that on salt subphases, with a marked increase in the area observed on the salt solutions. This behavior was noted for both forms of the porphyrin and both salts investigated. Modeling of specular X-ray reflectometry data indicated that thinner and more electron dense layers on salt subphases best fit the observed profiles. These data suggest that the porphyrin macrocycle is oriented parallel to the interface on salt subphases and takes on a tilted conformation on pure water. In the case of ZnTPyP, PTRXAS was used to determine the orientation of the porphyrin moiety relative to the surface and to probe the coordination of the central Zn ion. In agreement with the pressure-area isotherms and reflectometry, the PTRXAS data indicate a change in orientation on the salt subphases.

Nanoscale tubular vessels for storage of methane at ambient temperatures

Novel carbon nanostructures can serve as effective storage media for methane, a source of clean energy for the future. We have used Grand Canonical Monte Carlo Simulation for the modeling of methane storage at 293 K and pressures up to 80 MPa in idealized bundles of (10,10) armchair-type single-walled carbon nanotubes and wormlike carbon pores. We have found that these carbon nanomaterials can be treated as the world's smallest high-capacity methane storage vessels. Our simulation results indicate that such novel carbon nanostructures can reach a high volumetric energy storage, exceeding the US FreedomCAR Partnership target of 2010 (5.4 MJ dm(-3)), at low to moderate pressures ranging from 1 to 7 MPa at 293 K. On the contrary, in the absence of these nanomaterials, methane needs to be compressed to approximately 13 MPa at 293 K to achieve the same target. The light carbon membranes composed of bundles of single-walled carbon nanotubes or wormlike pores efficiently physisorb methane at low to moderate pressures at 293 K, which we believe should be particularly important for automobiles and stationary devices. However, above 15-20 MPa at 293 K, all investigated samples of novel carbon nanomaterials are not as effective when compared with compression alone since the stored volumetric energy and power saturate at values below those of the bulk, compressed fluid.

Allergy - 5: Allergy and the skin: eczema and chronic urticaria

Eczema is common, occurring in 15%-20% of infants and young children. For some infants it can be a severe chronic illness with a major impact on the child's general health and on the family. A minority of children will continue to have eczema as adults. The exact cause of eczema is not clear, but precipitating or aggravating factors may include food allergens (most commonly, egg) or environmental allergens/irritants, climatic conditions, stress. and genetic predisposition. Management of eczema consists of education; avoidance of triggers and allergens; liberal use of emollients or topical steroids to control inflammation; use of antihistamines to reduce itch; and treatment of infection if present. Treatment with systemic agents may be required in severe cases, but must be supervised by an immunologist. Urticaria (hives) may affect up to a quarter of people at some time in their lives. Acute urticaria is more common in children, while chronic urticaria is more common in adults. Chronic urticaria is not life-threatening, but the associated pruritus and unsightly weals can cause patients much distress and significantly affect their daily lives. Angioedema coexists with urticaria in about 50% of patients. It typically affects the lips, eyelids, palms, soles and genitalia. Management of urticaria is through education; avoidance of triggers and allergens (where relevant); use of antihistamines to reduce itch; and short-term use of corticosteroids when antihistamine therapy is ineffective. Referral is indicated for patients with resistant disease.